Eliem Therapeutics (ELYM)
NASDAQ:ELYM
US Market
Holding ELYM?
Track your performance easily

Eliem Therapeutics (ELYM) Financial Statements

35 Followers

Eliem Therapeutics Financial Overview

Eliem Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.148; its P/E ratio is -3.72; Eliem Therapeutics is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 33.00K----
Gross Profit$ 33.00K----
EBIT$ -54.89M$ -3.00M$ -5.00M$ -5.16M$ -22.03M
EBITDA$ -54.89M$ -3.00M$ -5.00M$ -5.90M$ -22.52M
Net Income Common Stockholders$ -54.89M$ -1.70M$ -3.97M$ -5.22M$ -22.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 223.14M$ 105.00M$ 107.43M$ 102.63M$ 109.37M
Total Assets$ 226.02M$ 109.30M$ 112.73M$ 116.27M$ 122.08M
Total Debt$ 100.00K$ 225.00K$ 459.00K$ 585.00K$ 687.00K
Net Debt$ -223.04M$ -104.78M$ -106.97M$ -102.05M$ -108.69M
Total Liabilities$ 3.74M$ 2.95M$ 2.99M$ 3.77M$ 5.22M
Stockholders Equity$ 222.28M$ 106.36M$ 109.74M$ 112.47M$ 116.81M
Cash Flow-
Free Cash Flow$ -5.31M$ -1.82M$ 3.49M$ -7.96M$ -15.18M
Operating Cash Flow$ -667.00K$ -1.82M$ 3.49M$ -7.96M$ -15.18M
Investing Cash Flow$ -9.64M$ 13.75M$ 28.04M$ -1.60M$ 5.80M
Financing Cash Flow$ 128.40M$ 15.00K$ 528.00K$ 24.00K$ 1.00K
Currency in USD

Eliem Therapeutics Earnings and Revenue History

Eliem Therapeutics Debt to Assets

Eliem Therapeutics Cash Flow

Eliem Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis